glp-1 news today pharma The next phase of the obesity drug race The GLP-1 effect on MedTech
Pay in 4 interest-free payments of $7.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
The GLP 1 effect on MedTech Strategy& MedImpact Launches New GLP 1 Solutions to Address Rising Obesity Care Costs Pharmaceutical Commerce GLP 1: Just a wonder drug or a lifesaver for millions? Niveshaay A $60 billion industry just found its next growth lever. With the expiry of a key patent on March 20, 2026, Indian pharma majors are launching generic weight loss and diabetes drugs India is a weird market. With obesity rates shooting up, I'd have bet on the sales of generic GLP 1s exploding once their patents expired. They now cost about Rs 1,0002,500 a month Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP 1, but Wall Street isn't celebrating Drug Discovery and Development
Store: psychwardcomics.com · Domain: psychwardcomics.com























